Roche broadens Regeneron’s reach in COVID-19 antibody deal 

By partnering with Roche, Regeneron is broadening the reach of its COVID-19 antiviral antibody cocktail outside the U.S., gaining manufacturing capacity to deliver a total number of doses that could extend into the millions and a partner with the reach to seek approval of and distribute the product around the globe. 

Following an EMA approval for REGN-COV2, Roche (SIX:ROG; OTCQX:RHHBY) will be responsible for securing additional ex-U.S. approvals and distribution...